Galapagos (GLPG) has the following price history information. Looking back at GLPG historical stock prices for the last five trading days, on May 01, 2024, GLPG opened at $28.30, traded as high as $29.44 and as low as $28.30, and closed at $29.34. Trading volume was a total of 149.90K shares. On May 02, 2024, GLPG opened at $28.91, traded as high as $29.65 and as low as $28.90, and closed at $29.45. Trading volume was a total of 122.80K shares. On May 03, 2024, GLPG opened at $29.10, traded as high as $29.44 and as low as $28.80, and closed at $29.09. Trading volume was a total of 125.70K shares. On May 06, 2024, GLPG opened at $29.33, traded as high as $29.66 and as low as $29.00, and closed at $29.47. Trading volume was a total of 69.40K shares. On May 07, 2024, GLPG opened at $29.53, traded as high as $29.54 and as low as $28.99, and closed at $29.08. Trading volume was a total of 83.10K shares.

GLPG Historical Stock Prices By Date:

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 20142015201620172018201920202021202220232024

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Galapagos shares, starting with a $10,000 purchase of GLPG, and working forward through the historical stock price information to today.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	04/23/2015
End date:	05/07/2024
Start price/share:	$35.57
End price/share:	$29.08
Dividends collected/share:	$0.00
Total return:	-18.25%
Average Annual Total Return:	-2.20%
Starting investment:	$10,000.00
Ending investment:	$8,177.11
Years:	9.05

GLPG Historical Price Range
Date	Open	High	Low	Close	Volume
05/01/2024	$28.30	$29.44	$28.30	$29.34	149.90K
05/02/2024	$28.91	$29.65	$28.90	$29.45	122.80K
05/03/2024	$29.10	$29.44	$28.80	$29.09	125.70K
05/06/2024	$29.33	$29.66	$29.00	$29.47	69.40K
05/07/2024	$29.53	$29.54	$28.99	$29.08	83.10K

About Galapagos

Galapagos is a biopharmaceutical company engaged in the discovery, development, and commercialization of medicines with modes of action, addressing disease areas of unmet medical need. Co.'s clinical pipeline includes: preferential JAK1 inhibitor filgotinib, which is approved for the treatment of rheumatoid arthritis in Europe and Japan, and in a trial in Crohn's disease; GLPG1205, which is a GPR84 inhibitor that engages in the idiopathic pulmonary fibrosis (IPF) trial with IPF patients; GLPG4716, which is a chitinase inhibitor that engages in preparation for a study in IPF; and Toledo molecule GLPG3970, which is a SIK2/3 inhibitor that engages in Proof of Concept trials.

GLPG Historical Closing Prices
Date	Close
05/01/2024	$29.34
05/02/2024	$29.45
05/03/2024	$29.09
05/06/2024	$29.47
05/07/2024	$29.08

GLPG Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.